Noble Infusion urges early action for mild cognitive impairment
It highlights FDA-approved infusions Kisunla and Leqembi, which may slow Alzheimer's progression when started early, and offers IV therapy at its Daytona Beach-area center.
See the latest news and media coverage for Noble Infusion. We track all announcements, press releases, and industry mentions in real time, all in one place.
Last updated
It highlights FDA-approved infusions Kisunla and Leqembi, which may slow Alzheimer's progression when started early, and offers IV therapy at its Daytona Beach-area center.
The treatment targets underlying inflammation and offers a less invasive alternative to surgery, with infusions available in a comfortable setting.
The once-monthly IV infusion reduces amyloid plaques by up to 84% at 18 months and slows cognitive decline by 35% versus placebo.
Patients can have their doctor send orders to the Ormond Beach or Port Orange centers and schedule weekly, bi-weekly or monthly treatments.
Infusion therapies can be "life changing" for those suffering from chronic illnesses, founder Shaya Fogel said.
Track Noble Infusion and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.